Target Name: GPR22
NCBI ID: G2845
Review Report on GPR22 Target / Biomarker Content of Review Report on GPR22 Target / Biomarker
GPR22
Other Name(s): G-protein coupled receptor 22 | G protein-coupled receptor 22 | probable G-protein coupled receptor 22 | GPR22_HUMAN

GPR22: A Potential Drug Target and Biomarker for Many Diseases

G-protein coupled receptor 22 (GPR22) is a protein that is expressed in many different tissues throughout the body. It is a member of the G-protein coupled receptor family, which is a large superfamily of transmembrane proteins that play an important role in cellular signaling. GPR22 is characterized by its unique structure, which consists of a long extracellular domain, a short intracellular domain, and a short catalytic domain.

One of the key functions of GPR22 is its role in cell signaling. GPR22 is involved in a wide range of signaling pathways, including the regulation of pain, inflammation, and neurotransmitter signaling. It is also involved in the regulation of cell survival and proliferation, as well as the regulation of cell adhesion.

GPR22 is a potential drug target for a variety of diseases. For example, GPR22 has been shown to be involved in the regulation of pain, and is thought to play a role in the development of chronic pain. It is also involved in the regulation of inflammation, and has been shown to play a role in the regulation of autoimmune diseases. In addition, GPR22 is involved in the regulation of neurotransmitter signaling, and is thought to play a role in the treatment of neurodegenerative diseases.

Another potential application of GPR22 is as a biomarker for disease diagnosis and monitoring. GPR22 is expressed in many different tissues and cells, and its expression can be affected by a wide range of factors, including disease status, drug treatment, and environmental conditions. This makes GPR22 an attractive candidate for use as a biomarker for a variety of diseases. For example, GPR22 expression has been shown to be elevated in a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. It is also thought to be involved in the regulation of pain, and its expression has been shown to be elevated in individuals with chronic pain.

In conclusion, GPR22 is a protein that is involved in a wide range of cell signaling pathways. It is a potential drug target for a variety of diseases, including pain, inflammation, and neurotransmitter signaling. Its unique structure and broad range of functions make it an attractive candidate for use as a biomarker in a variety of diseases. Further research is needed to fully understand the role of GPR22 in cell signaling and its potential as a drug and biomarker.

Protein Name: G Protein-coupled Receptor 22

Functions: Orphan G-protein coupled receptor. Seems to act through a G(i)/G(o) mediated pathway (PubMed:18539757). May be involved in ciliogenesis (By similarity)

The "GPR22 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR22 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme | GRAP | GRAP2 | GRAPL | GRAPL-AS1 | GRASLND | GRB10 | GRB14 | GRB2 | GRB7 | GREB1 | GREB1L | GREM1 | GREM1-AS1 | GREM2 | GREP1 | GRHL1 | GRHL2 | GRHL3 | GRHL3-AS1 | GRHPR | GRIA1 | GRIA2